Seema Nayak

Also affiliated with Medanta The Medicity, National Institute of Allergy and Infectious Diseases

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 23 papers. Top paper: “Remdesivir for the Treatment of Covid-19 — Final Report”.

Remdesivir for the Treatment of Covid-19 — Final Report

New England Journal of Medicine(2020)10.1056/nejmoa2007764

N/A

12.3DataRank · unranked

7738 citations

Kay M Tomashek, Lori E. Dodd, Aneesh K. Mehta, Barry S. Zingman, André C. Kalil +35 more

Homologous and Heterologous Covid-19 Booster Vaccinations

New England Journal of Medicine(2022)10.1056/nejmoa2116414

N/A

9.7DataRank · unranked

618 citations

Kirsten E. Lyke, Meagan E. Deming, Lisa A. Jackson, Angela R Branche, Hana M. El Sahly +33 more

Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19

New England Journal of Medicine(2020)10.1056/nejmoa2031994

N/A

6.8DataRank · unranked

1924 citations

Thomas F. Patterson, Aneesh K. Mehta, Kay M Tomashek, Cameron R. Wolfe, Varduhi Ghazaryan +55 more

Rapid decline in vaccine-boosted neutralizing antibodies against SARS-CoV-2 Omicron variant

Cell Reports Medicine(2022)10.1016/j.xcrm.2022.100679

N/A

5.1DataRank · unranked

167 citations

Robert L. Atmar, Clara Domínguez Islas, Christine M. Posavad, Daniel Szydlo, Rahul Paul Chourdhury +64 more

Heterologous SARS-CoV-2 Booster Vaccinations – Preliminary Report

medRxiv(2021)10.1101/2021.10.10.21264827

N/A

5.1DataRank · unranked

98 citations

Kirsten E. Lyke, Meagan E. Deming, Lisa A. Jackson, Angela R Branche, Hana M. El Sahly +33 more

Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial

The Lancet Respiratory Medicine(2022)10.1016/s2213-2600(22)00088-1

N/A

3.0DataRank · unranked

128 citations

Kay M Tomashek, Thomas F. Patterson, Carlos A. Gómez, Vincent C. Marconi, Mamta K. Jain +95 more

SARS-CoV-2 Variant Vaccine Boosters Trial: Preliminary Analyses

medRxiv(2022)10.1101/2022.07.12.22277336

N/A

1.6DataRank · unranked

30 citations

Nadine Rouphael, David Diemert, Ann R. Falsey, Cecilia Losada, Lindsey R. Baden +63 more

Safety and microbiological activity of phage therapy in persons with cystic fibrosis colonized with Pseudomonas aeruginosa: study protocol for a phase 1b/2, multicenter, randomized, double-blind, placebo-controlled trial

Trials(2022)10.1186/s13063-022-07047-5

N/A

1.4DataRank · unranked

64 citations

Maria Souli, Michael Billard, J Campbell, Douglas Conrad, Damon W. Ellison +20 more

Comparison of bivalent and monovalent SARS-CoV-2 variant vaccines: the phase 2 randomized open-label COVAIL trial

Nature Medicine(2023)10.1038/s41591-023-02503-4

N/A

1.3DataRank · unranked

56 citations

Nadine Rouphael, David Diemert, Ann R. Falsey, Cecilia Losada, Lindsey R. Baden +94 more

Immunogenicity of NVX-CoV2373 heterologous boost against SARS-CoV-2 variants

npj Vaccines(2023)10.1038/s41541-023-00693-z

N/A

1.1DataRank · unranked

33 citations

Robert L. Atmar, Clara Domínguez Islas, Christine M. Posavad, Meagan E. Deming, Angela R Branche +69 more

Temporal Improvements in COVID-19 Outcomes for Hospitalized Adults: A Post Hoc Observational Study of Remdesivir Group Participants in the Adaptive COVID-19 Treatment Trial

Annals of Internal Medicine(2022)10.7326/m22-2116

N/A

0.434DataRank · unranked

6 citations

Tyler Bonnett, Kevin Rubenstein, David A Lindholm, Rekha R. Rapaka, Sarah B. Doernberg +39 more

A Risk Profile Using Simple Hematologic Parameters to Assess Benefits From Baricitinib in Patients Hospitalized With COVID-19: A Post Hoc Analysis of the Adaptive COVID-19 Treatment Trial-2

Annals of Internal Medicine(2024)10.7326/m23-2593

N/A

0.376DataRank · unranked

6 citations

Jing Wang, Kay M. Tomashek, Tyler Bonnett, Kanal Singh, Vincent C. Marconi +16 more

Bivalent and Monovalent SARS-CoV-2 Variant Vaccine Boosters Improve coverage of the known Antigenic Landscape: Results of the COVID-19 Variant Immunologic Landscape (COVAIL) Trial

Research Square(2023)10.21203/rs.3.rs-2653179/v1

N/A

0.372DataRank · unranked

5 citations

Nadine Rouphael, David Diemert, Ann R. Falsey, Cecilia Losada, Lindsey R. Baden +63 more

Mucosal and Systemic Antibody Responses After Boosting With a Bivalent Messenger RNA Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine

The Journal of Infectious Diseases(2025)10.1093/infdis/jiaf176

N/A

0.284DataRank · unranked

4 citations

Kirsten E. Lyke, Christine M. Posavad, Meagan E. Deming, Rebecca C. Brady, David Dobrzynski +32 more

Neutralizing Antibody Immune Correlates for a Recombinant Protein Vaccine in the COVAIL Trial

Clinical Infectious Diseases(2024)10.1093/cid/ciae465

N/A

0.251DataRank · unranked

3 citations

Lauren Dang, Bo Zhang, Jonathan Fintzi, Shiyu Chen, Jing Wang +84 more

Evaluating Demographic Representation in Clinical Trials: Use of the Adaptive Coronavirus Disease 2019 Treatment Trial (ACTT) as a Test Case

Open Forum Infectious Diseases(2023)10.1093/ofid/ofad290

N/A

0DataRank · unranked

2 citations

Noreen A. Hynes, Corri B. Levine, Katherine Yang, Zanthia Wiley, Nikolaus Jilg +37 more

Durability of mRNA-1273 vaccine–induced antibodies against SARS-CoV-2 variants

Science(2021)10.1126/science.abj4176

N/A

0DataRank · unranked

602 citations

Sarah O’Connell, Stephen D. Schmidt, Sijy O’Dell, Chloe Adrienna Talana, Lilin Lai +82 more

Priorities and Progress in Gram-negative Bacterial Infection Research by the Antibacterial Resistance Leadership Group

Clinical Infectious Diseases(2023)10.1093/cid/ciad547

N/A

0DataRank · unranked

21 citations

David van Duin, Pranita D. Tamma, Thomas P. Lodise, Daria Van Tyne, Keith A. Rodvold +48 more

ACTIV trials: cross-trial lessons learned for master protocol implementation

Journal of Clinical and Translational Science(2024)10.1017/cts.2024.507

N/A

0DataRank · unranked

3 citations

Stacey J. Adam, Indira Brar, Lucy Chung, Judith S. Currier, Eric S. Daar +16 more

ACTIV trials: Lessons learned in trial design in the setting of an emergent pandemic

Journal of Clinical and Translational Science(2024)10.1017/cts.2024.1

N/A

0DataRank · unranked

1 citations

Kevin J. Anstrom, Christina E. Barkauskas, Samuel M. Brown, Eric S. Daar, William A. Fischer +16 more

ACTIV trials: Lessons learned in trial design in the setting of an emergent pandemic

UNC Libraries(2024)10.17615/wtgx-4h88

N/A

0DataRank · unranked

0 citations

Mahesh Parmar, Roger Paredes, Kevin J. Anstrom, Stacey J. Adam, Seema Nayak +16 more

Neutralizing antibody immune correlates in COVAIL trial recipients of an mRNA second COVID-19 vaccine boost

Nature Communications(2025)10.1038/s41467-025-55931-w

N/A

0DataRank · unranked

9 citations

Youyi Fong, Lauren Dang, Jonathan Fintzi, Shiyu Chen, Jing Wang +43 more

The Antibacterial Resistance Leadership Group: Scientific Advancements and Future Directions

Clinical Infectious Diseases(2023)10.1093/cid/ciad475

N/A

0DataRank · unranked

9 citations

H. R. Cross, Maria Souli, Scott Evans, Robin Patel, Vance G. Fowler +60 more